BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 26 2024
0mins
Source: NASDAQ.COM
Quarterly Performance: BioHarvest Sciences Inc. reported a quarterly loss of $0.16 per share, significantly worse than the expected loss of $0.05, and revenues of $6.54 million, missing estimates by 2.26%. The company has only surpassed consensus EPS estimates once in the last four quarters.
Market Outlook: Despite underperforming compared to the S&P 500 this year, the stock holds a Zacks Rank #3 (Hold), indicating it is expected to perform in line with the market. Future performance will depend on management's commentary and earnings estimate revisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
